Corcept Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$41.56
Previous Close
$41.87
Day Range
$41.56-$42.45
52W Range
$28.66-$91
Market Cap
$4.4B
Shares Short
13M

Financials

See more
Revenue (12 Mos)
$761.4M
Revenue Growth (YoY)
11.1%
Gross Profit (12 Mos)
$748.4M
Diluted EPS
$0.82

News

See more

Yahoo Finance • 22 hours ago

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure

Yahoo Finance • 2 days ago

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Yahoo Finance • 2 days ago

DEADLINE ALERT for KD, PYPL, SMR, and CORT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Yahoo Finance • 3 days ago

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm

About

CEO
Dr. Joseph K. Belanoff M.D.
CFO
Mr. Atabak Mokari
Address
101 Redwood Shores Parkway, Redwood City, CA, United States, 94065
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
730